Swiss Chemicals Stock News

The market has happily paid up for VZ Holding, with the stock at CHF175.40 and a rich P/E of 29.3x versus far cheaper peers. Today's H1 earnings land into that optimism with a clear headline. Profitability stayed strong, with a trailing net margin of 37.6%, and fresh client money kept flowing, with CHF3,300m of net inflows. The sentiment test now is simple. Are investors rewarding a genuinely premium wealth manager, or stretching the valuation on earnings that grew more slowly than in recent...

Montana Aerospace walked into this earnings season with a reputation for high growth expectations and a rich 42.1x P/E, yet the stock now sits at CHF27.30 after a strong 30 day run of about 25%. The headline from this quarter is simple: profitability caught up with the story. Q2 2026 revenue reached €278.3m and net income from ongoing operations came in at €19.1m, helping lift trailing net profit margins to 4.2%. The key question for you now is whether this earnings power still justifies...

In August 2026, St. Galler Kantonalbank AG reported half-year results showing net interest income of CHF 190.17 million and net income of CHF 119.87 million for the period ended June 30, 2026, both higher than a year earlier. The simultaneous rise in net interest income and net income points to stronger core banking operations and tighter cost and risk control. We will now examine how this improvement in net interest income shapes St. Galler Kantonalbank’s broader investment narrative for...

The market has cooled on Kuros Biosciences over the past week, with the stock down about 5% even as the latest report marks the first profitable half year in the company’s history. That disconnect between a softer share price and a clear profitability milestone is the core sentiment test for investors today. H1 2026 brought total revenue of US$92.4m and net profit of US$4.4m, backed by a 13.6% adjusted EBITDA margin. For a high growth medtech that only recently crossed into the black, this...

Galenica (SWX:GALE) is back in focus after its half year 2026 results showed higher sales and revenue alongside lower net income, while the company reaffirmed its 2026 guidance for net sales and EBIT growth. See our latest analysis for Galenica. Galenica’s recent half year results and confirmed 2026 guidance come after a share price that is down 17.6% year to date to CHF81.1, while the 5 year total shareholder return of 31.1% points to a stronger longer term picture. Short term share price...

Thurgauer Kantonalbank stock has gone almost nowhere over the past week, yet the latest earnings quietly pushed the story a little further ahead. Net income over the last twelve months sits at CHF 162.967m while the P/E multiple is about 20.2x, above the European banks average. The real tug of war today is between that premium pricing and a net profit margin of 36.8% that slightly trails last year. The question for investors is whether this modest margin squeeze justifies any strong emotional...

Glarner Kantonalbank stock has been grinding higher in recent weeks, with a 3‑month gain in double digits. Today the focus sits squarely on what those earnings are doing to profitability. The headline is margins. Net profit margin for the last twelve months stands at 25%, compared with 22.7% a year earlier, which helps explain why the stock screens on investors’ radars even with a P/E of 13.4x. Short‑term traders may fixate on today’s price move. Longer term investors will likely pay more...

Restylane Shaype launch puts Galderma Group in focus Galderma Group (SWX:GALD) has drawn fresh investor attention after securing European Union approval for Restylane Shaype, a hyaluronic acid gel designed specifically for minimally invasive chin shaping and augmentation. See our latest analysis for Galderma Group. The Restylane Shaype approval lands at a time when Galderma Group’s share price has eased in the very short term, with the 1 day and 7 day share price returns declining 3.11% and...

Swiss Re (SWX:SREN) is drawing fresh attention after its H1 2026 results, with net income of US$2.831b and basic earnings per share of US$9.57 for the six months to June 30. See our latest analysis for Swiss Re. Swiss Re's share price has climbed over the past quarter, with a 90 day share price return of 14.82% and a year to date share price return of 7.15%. The 3 year total shareholder return of 93.41% highlights how long term holders have been rewarded, as recent earnings keep interest in...

Komax Holding shares closed at CHF78.70 on Friday, only modestly higher over the past week and month, which suggests investors came into these results cautiously optimistic but not euphoric. The earnings headline is simple and uncomfortable. The wiring automation specialist is still loss making, with a basic earnings per share loss of CHF0.96 in the first half and trailing twelve month losses that remain in the mid single digit millions of francs. The key issue now is valuation. The stock...

Alcon (SWX:ALC) is back in focus after its second quarter 2026 earnings report. The results showed higher sales and revenue but a much lower net income figure, giving investors mixed signals to digest. See our latest analysis for Alcon. The recent earnings announcement, maintained 2026 net sales growth guidance, and the RxSight collaboration have come alongside a 90 day share price return of 17.97%, although the 1 year total shareholder return is down 13.93%. If this mix of earnings and...

Temenos (SWX:TEMN) has drawn fresh attention after its Board of Directors approved a share repurchase program of up to CHF 100 million, with the buyback running until February 26, 2027. See our latest analysis for Temenos. The buyback news comes after a mixed period for Temenos, with the share price at CHF73.25 and a 7 day share price return of 5.40% signalling short term momentum. The year to date share price return is down 10.12% and the 5 year total shareholder return is down 43.34%. If...

ARYZTA (SWX:ARYN) has come into focus after reporting half year 2026 results that showed slightly lower sales and earnings. Investors are weighing what these updated figures mean for the stock. See our latest analysis for ARYZTA. ARYZTA's recent half year 2026 update comes after a tougher stretch for the stock, with the share price at CHF45.25 and the 30 day share price return down 18.32%. The 1 year total shareholder return is down 39.22%, which points to fading momentum as investors...

PolyPeptide Group’s share price closed at CHF44 on Thursday, exactly where Samsung Biologics has pitched its all cash tender offer at CHF44.31. The market is trading the stock as if the deal price already tells the whole story. The earnings print suggests a different perspective. The key development is the rise in profitability. Revenue in the first half of 2026 reached €236.6m and earnings before interest, tax, depreciation and amortisation were €49.1m, with an underlying margin near 19%...

Adecco Group (SWX:ADEN) unit LHH Career Studio has received the Career Development Innovation Award at the 2026 HR Tech Breakthrough Awards. The award recognizes LHH Career Studio's AI powered career transition platform for its role in digital talent solutions. The recognition comes as Adecco Group continues to focus on AI and digital transformation across its services. Readers looking for more ideas in AI focused talent and HR technology can explore 130 AI small caps. SWX:ADEN Earnings &...

Swissquote Group Holding heads into the post earnings session with a stock that has drifted lower in recent weeks, despite a profit story that still looks powerful. The market has marked the share price down over the past month, yet trailing net income and earnings per share point to a business that continues to convert revenue into profit at a high level. The heart of this release is margin resilience. A trailing net profit margin above 40% indicates that Swissquote is still keeping a very...

Basler Kantonalbank stock has cooled in recent weeks, with the share price drifting about 3% lower over the past month and sitting at CHF94.40 into the H1 2026 release. The earnings story, however, centers on profitability. Net profit margins over the last 12 months stand at 31.2%, while the P/E of 19.4x reflects a valuation premium compared with much of the European banking sector. For you as an investor, the question now is simple: do the strong margins and the 3.81% dividend yield justify...

Nestlé stock in focus after renewed growth narrative Nestlé (SWX:NESN) is back on investors’ radar after recent coverage highlighted its profitability trends and focus on health science nutrition, pet care, premium coffee and related protein segments linked to growing whey protein demand. See our latest analysis for Nestlé. Nestlé’s share price has climbed 6.06% year to date to CHF81.07, while a 17.08% total shareholder return over the past year suggests that investors are gradually warming...

Basellandschaftliche Kantonalbank came into this earnings day with a drifting share price, down over the past week and past month, while trading on a trailing P/E of 15.4x that sits between local peers and the wider European banks sector. The new H1 2026 numbers put the focus squarely on profitability pressure. Trailing net income of CHF 149.5m now converts into a slimmer net margin of 29.4%, well below last year. For a stock that some investors viewed as undervalued on discounted cash flow,...

Berner Kantonalbank shares closed at CHF373 after a soft few weeks, with the stock down over the past month even as the latest half year numbers land. The market looks more cautious than euphoric. That caution meets a bank still reporting high profitability, with a trailing net margin of 32.3% and earnings from continuing operations of CHF181.7 million over the past twelve months. The key issue now is valuation. Berner Kantonalbank trades on a 19x P/E, above the wider European banks sector,...

As European equities experience a boost from resilient earnings and improved risk appetite, the pan-European STOXX Europe 600 Index has seen notable gains, reflecting broader optimism in the market. In this environment, dividend stocks stand out as attractive options for investors seeking stable income and potential growth, offering a compelling way to enhance portfolio resilience amidst ongoing economic uncertainties.

ams-OSRAM (SWX:AMS) shares are in focus after the company reported Q2 2026 results showing higher sales but a larger net loss, alongside fresh Q3 guidance and a softer full year revenue outlook. See our latest analysis for ams-OSRAM. The Q2 update and new Q3 guidance follow a strong rebound in ams-OSRAM's share price, with a year-to-date share price return of 122.75% and a 1-year total shareholder return of 81.21%, although the 5-year total shareholder return is down 79.53%. If this earnings...

The European stock market has recently shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.70% amid firmer risk appetite and robust earnings, despite a volatile geopolitical environment. As investors navigate these conditions, identifying undervalued stocks becomes crucial for capitalizing on potential opportunities within this fluctuating landscape.

Alcon stock closed at CHF61.06 on 11 August after a strong run over the past quarter. Yet the real story now sits in the income statement. Q2 sales landed at about US$2.8b with 7% growth, but the headline tension for investors is profits. Trailing 12 month net profit margin is 5.9% compared with 10.7% a year earlier, held back by a US$453m one off loss that still hangs over reported earnings. For anyone thinking beyond this quarter, the key question is how quickly those margins can rebuild as...